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Snakebite – A neglected threat to public health 
Globally, more than 5.5 million people are bitten by venomous snakes every year, leading to an estimated 
125,000 deaths and 3 times as many amputations [1,2,3]. The problem is most prevalent in Sub-Saharan 
Africa where affordability of antivenom is low, resulting in only 2% of snakebite victims receiving treatment 
[1,4]. Since the introduction of antivenoms in the 1890’s, only modest advances in antivenom technology and 
production have been made. Current antivenoms are, therefore, still being produced by immunisation of large 
ruminants, typically horses, with snake venoms and subsequently bleeding them to collect blood comprising 
venom-specific antibodies [4]. The incompatibility of these antivenoms with the  human immune system can 
lead to serious adverse effects [1,5]. A novel approach is needed in order to introduce safer, cheaper and 
more efficacious antivenoms that are compatible with the human immune system to the market. 
Figure 2: Phage display is a screening technique whereby peptides are displayed on the surface of 
bacteriophages, some of which bind with high affinity to snake toxins that are attached to plate wells.  
We attempt to discover cross-reactive, 
peptide-based antitoxins against the 
structurally similar dendrotoxins α-
dendrotoxin (α-Dtx, UniProtKB 
P00980), isolated from Dendroaspis 
angusticeps (Green mamba), and 
dendrotoxin I (Dtx I, UniProtKB 
P00979) from Dendroaspis polylepis 
(Black mamba) by phage display [5,6]. 
Cross-reactive antitoxins with the 
ability to neutralise several toxins are 
of interest to antivenom development, 
since only a few cross-reactive 
antitoxins would be needed to 
neutralise a complete snake venom 
[4]. 
 
Method – Identification of binders with phage display 
Initially, sequence alignment using the protein Needleman-Wunsch algorithm from EMBL-EBI was performed 
(Figure 3). Additionally, 3D structural models of the two toxins  were constructed and compared. The structure 
of α-Dtx was based upon the available X-ray crystallographic structure with PDB entry 1DTX whilst the 
structure of Dtx I was estimated based on a model of the Kunitz-type serine protease inhibitor (PDB entry: 
3BYB), isolated from Pseudonaja textilis (brown snake) using the Bioinformatics Toolkit developed by the Max-
Planck Institute, Tübingen (Figure 3). 
Results – Cross-reactivity based on similarity 
Based on ELISA, strong binding to Dtx I was observed for the polyclonal phage library after the third round of 
panning (Figure 4), yet randomly selected monoclonal phages did not show strong binding to Dtx I (Figure 5). 
It was observed that the polyclonal phage library also bound to α-Dtx (data not shown), indicating a high 
degree of cross-reactivity. This was anticipated by the bioinformatics modelling of the dendrotoxins, illustrating 
a high degree of similarity in both their primary, secondary, and tertiary structures (Figure 3). 
Outlook – Discovery of antitoxins for mamba toxins 
Polyclonal phages with strong binding affinity, high specificity, yet displaying cross-reactivity, were discovered 
using phage display. However,  due to time limitations, no individual monoclonal phage was found to have 
both high affinity and show selectivity towards the toxins. 
Subsequent steps could include further analysis of other monoclonal phages or repetition of the fourth round 
of panning in order to attempt to amplify phages with high affinity and specificity. If a high-affinity toxin binder 
were to be identified, this binder could 1) be applied as a peptide-based antitoxin, 2) be used to create a 
peptidomimetic antitoxin or 3) be grafted onto an antibody as a CDR region, paving the way for safer and 
more efficacious antivenoms.   
Figure 1: Dendroaspis polylepis (black mamba). Photo: Larsa D. 2011 
Figure 3: Surface models and overlapping cartoon models of α-dendrotoxin (α-Dtx) and dendrotoxin I (Dtx I) 
from D. angusticeps and D. polylepis , respectively, illustrating the largely similar secondary and tertiary 
structures of the two toxins. Models are drawn in PyMOL. Sequence similarity of 90% is observed when 
performing sequence alignment using the protein Needleman-Wunsch algorithm from EMBL-EBI.  
Figure 4: ELISA results 
(Absorbance at 490 nm). 
Iterative rounds of panning of 
the phages leads to amplification 
of good binders. The polyclonal 
phage library from the third 
round of panning yields a strong 
ELISA signal as well as a signal 
ratio of 8.6 between Dtx I and 
PBS + skim milk control, 
indicating the presence of strong 
peptide binders to Dtx I. 
α-Dtx Overlay of cartoon 
models  of  α-Dtx 
and Dtx I 
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neurotoxin 
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Dtx I   QPLRKLCILHRNPGRCYQKIPAFYYNQKKKQCEGFTWSGCGGNSNRFKTIEECRRTCIRK   60    
    ||.||||||||||||||.|||||||||||||||.|.|||||||||||||||||||||| . 
α-Dtx   QPRRKLCILHRNPGRCYDKIPAFYYNQKKKQCERFDWSGCGGNSNRFKTIEECRRTCI-G   59 
Figure 5: ELISA results (Absorbance at 490 nm) showing the signal ratio between binding to Dtx I and the 
PBS + skim milk control for 10 selected phage monoclones from the third round of panning. An additional 20 
phage monoclones were selected and tested for binding to Dtx I (data not shown); however, better binders 
were not observed. The best binder is Phage Monoclone 8, which shows some degree of binding, but only a 
specificity of 2:1 for Dtx I vs. the PBS + skim milk control. 
Phage display was applied to discover binders to Dtx I and α-Dtx (Figure 2). Phage display is a screening 
technique, where a library of peptides is engineered to be expressed on the surface of bacteriophages by 
genetic fusion with a phage coat protein [7]. In order to identify specific binders, the mamba snake neurotoxins 
are attached to plate wells (Reacti-Bind™ plate) and, subsequently, the phage library is added to the wells. 
Phages that display a relevant peptide on their coat will be retained whilst unbound phages will be washed 
away. Iterative rounds of binding result in amplification of the phages expressing high-affinity peptides [7].   
0
0,5
1
1,5
2
2,5
1 2 3 4 5 6 7 8 9 10
Ratio 
Phage monoclones 1 to 10 
0
1
2
3
4
1 2 3 4 5
Abs,  
490 nm 
Rounds of Panning 
Dtx I Library (coat: Dtx I) Dtx I Library (coat: PBS)
